What is the optimal distal resection margin for esophageal carcinoma?

被引:56
作者
Casson, AG [1 ]
Darnton, SJ [1 ]
Subramanian, S [1 ]
Hiller, L [1 ]
机构
[1] Birmingham Heartlands Hosp, Reg Dept Thorac Surg, Clin Trials Unit, CRC Inst Canc Studies, Birmingham B9 5ST, W Midlands, England
关键词
D O I
10.1016/S0003-4975(99)01262-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Whereas a proximal resection margin of 12 cm is recommended for complete resection of esophageal cancer, the extent of distal resection is unclear. Methods. We examined distal resection margins in a consecutive series of patients who underwent esophagectomy for squamous cell carcinomas (n = 50), primary esophageal adenocarcinomas (n = 100), and adenocarcinomas of the cardia (n = 39), in whom all macroscopic tumor was judged to be completely resected. Results. Microscopic tumor was found at a 3-cm distal resection margin for one multifocal squamous cell carcinoma. Positive distal resection margins were seen in 12% (12 of 100 patients) of primary esophageal adenocarcinomas (median, 2 cm versus 4 cm if negative; p = 0.002, Wilcoxon) and 28% (11 of 39 patients) of cardia adenocarcinomas (median, 1 cm versus 3 cm if negative; p = 0.02, Wilcoxon). Although pathologic stage was shown to be the only significant predictor of overall survival (Hazard ratio [HR] 1.8; 95% confidence interval 1.2 to 2.6; p = 0.007), there was a trend toward reduced postoperative survival for patients with histologically positive distal resection margins, in particular for patients with cardia adenocarcinomas (median, 15.4 months versus 5.7 months if negative; p = 0.0001). Conclusions. To achieve consistently negative distal resection margins, we recommend resection of at least 5 cm of macroscopically normal foregut below the distal margin of the primary tumor. (C) 2000 by The Society of Thoracic Surgeons.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 25 条
[1]   Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].
Bosset, JF ;
Gignoux, M ;
Triboulet, JP ;
Tiret, E ;
Mantion, G ;
Elias, D ;
Lozach, P ;
Ollier, JC ;
Pavy, JJ ;
Mercier, M ;
Sahmoud, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167
[2]   p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival [J].
Casson, AG ;
Tammemagi, M ;
Eskandarian, S ;
Redston, M ;
McLaughlin, J ;
Ozcelik, H .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (02) :71-79
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   RECENT CANCER TRENDS IN THE UNITED-STATES [J].
DEVESA, SS ;
BLOT, WJ ;
STONE, BJ ;
MILLER, BA ;
TARONE, RE ;
FRAUMENI, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :175-182
[5]   ESOPHAGEAL SQUAMOUS-CELL CARCINOMA .1. A CRITICAL-REVIEW OF SURGERY [J].
EARLAM, R ;
CUNHAMELO, JR .
BRITISH JOURNAL OF SURGERY, 1980, 67 (06) :381-390
[6]   Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria [J].
Ellis, FH ;
Heatley, GJ ;
Krasna, MJ ;
Williamson, WA ;
Balogh, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (05) :836-846
[7]   MEDICAL PROGRESS - GASTRIC-CARCINOMA [J].
FUCHS, CS ;
MAYER, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :32-41
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]   Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer [J].
Kelsen, DP ;
Ginsberg, R ;
Pajak, TF ;
Sheahan, DG ;
Gunderson, L ;
Mortimer, J ;
Estes, N ;
Haller, DG ;
Ajani, J ;
Kocha, W ;
Minsky, BD ;
Roth, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1979-1984
[10]  
KUANO H, 1992, BRIT J SURG, V79, P328